Rep. Daniel Webster

Maddy summaryHR 833 creates a federal tax credit for individuals and corporations that contribute to scholarship granting organizations (SGOs) providing scholarships for elementary and secondary education. The credit allows taxpayers to deduct up to 10% of their adjusted gross income or $5,000 (whichever is less) for contributions to SGOs serving students from households with income up to 300% of the area median income. The bill establishes a $10 billion annual cap on the tax credit program, requires SGOs to verify student eligibility and maintain separate accounts, and prohibits government control over SGOs or private schools. It ensures scholarships can be used at public, private, or religious schools without discrimination based on religious character. The tax credit would be available for contributions made after December 31, 2025, with annual volume cap increases based on usage.

Maddy summaryThis bill prohibits the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) from treating pregnancy as an illness when approving or regulating abortion drugs. It specifically bans using this framework for approvals under the Federal Food, Drug, and Cosmetic Act or for risk management strategies. The bill also nullifies existing approvals of abortion drugs (like mifepristone) that relied on treating pregnancy as an illness. This directly affects how the FDA regulates abortion medications, changing the basis for their safety and efficacy evaluations.

Maddy summaryThe Second Chance for Moms Act (HR 796) requires a new warning label on mifepristone - a medication used for medical abortions - stating that natural progesterone may counteract its effects and increase fetal survival, with a hotline reference for further information. It also mandates a federal 24/7 hotline providing support and referrals exclusively to healthcare providers offering "abortion pill reversal" services. This bill directly affects patients prescribed mifepristone and healthcare providers who dispense the medication, as the label must appear on packaging and the hotline must be established. The warning label would take effect six months after enactment, and the hotline would operate under the Public Health Service Act.

Maddy summaryHR 797, the Ultrasounds Save Lives Act of 2025, requires abortion providers to perform an ultrasound before an abortion (except in medical emergencies) and share the results with the patient. It mandates a specific informed consent form detailing the fetus's gestational age, medical risks, developmental stage (including heartbeat and organ development), and provider penalties for non-compliance. Violations trigger civil penalties of $100,000-$250,000 per incident, plus private lawsuits allowing patients to seek triple the abortion cost in damages. The law applies to licensed medical providers and those legally authorized to perform abortions, with exceptions only when ultrasound poses a direct risk to the patient's life or major bodily function.

Maddy summaryThis bill prohibits federal funds from being used to cover gender transition procedures for individuals under 18, including puberty blockers, hormone therapies (at higher-than-normal doses), and surgeries like hysterectomies or mastectomies. It defines "sex" biologically as male or female and exempts certain medical treatments, such as puberty suppression for precocious puberty or care for genetic disorders of sex development. The policy directly affects minors receiving federally funded healthcare (e.g., Medicaid), restricting coverage for most gender-affirming care. Key mechanisms include funding restrictions and specific medical exceptions, though it does not ban private insurance or out-of-pocket payments.

Maddy summaryThis bill requires abortion providers to give patients a consent form outlining disposal options for fetal remains (taking the remains or transferring them to interment/cremation services). Providers must arrange interment or cremation within 7 days if patients release remains, and face civil penalties up to $50,000 or criminal charges for noncompliance. It mandates annual reporting by providers on abortion procedures, gestational age, and disposal methods, with the Secretary submitting a separate report to Congress. The bill directly affects abortion providers and patients receiving abortion care, adding handling and reporting requirements for fetal remains without changing abortion access or medical procedures.

Maddy summaryHR 799, the Parental Notification and Intervention Act of 2025, requires healthcare providers to notify a minor's parents (or legal guardian) in writing before performing an abortion on an unemancipated minor under 18, with a 96-hour waiting period after notification. Parents may then seek a federal court injunction to halt the procedure, which would remain in effect until the court rules. The bill includes a medical emergency exception allowing abortions without notification if a physician certifies a life-threatening condition for the minor. This law directly affects minors under 18 seeking abortions, their parents/guardians, and healthcare providers performing such procedures in facilities receiving federal funds or operating across state lines.

Maddy summaryHR 719, the "No Abortion Coverage for Medicaid Act," would prohibit federal Medicaid funds from covering abortions under any Medicaid demonstration projects or waivers, with limited exceptions. It specifically blocks federal financial assistance for abortion services or related expenses (like travel) in Medicaid programs, except in cases of rape or incest, life-threatening pregnancy conditions, or treatment for miscarriage or ectopic pregnancy. This bill directly affects Medicaid recipients in states participating in federal demonstration projects, preventing them from using Medicaid funds for abortion services except under the narrow exceptions listed. The bill aims to permanently align Medicaid funding with the longstanding Hyde Amendment restrictions.

Maddy summaryHR 727 amends federal law to expand the definition of "valuable consideration" in transactions involving human fetal tissue. The bill specifically adds provisions to prohibit payments, waived fees, canceled debts, or free/discounted services related to tissue transportation, processing, storage, or implantation. This directly affects medical providers, laboratories, and facilities handling fetal tissue by restricting how they can receive compensation for these services. The key change clarifies that even indirect financial benefits, like reduced charges or waived costs, would be considered prohibited "valuable consideration."

Maddy summaryHR 729, the Teleabortion Prevention Act of 2025, prohibits healthcare providers from administering chemical abortions (using drugs to terminate pregnancy) via telehealth or remote means without being physically present during the procedure. It requires providers to physically examine the patient, be present at the location of the abortion, and schedule a follow-up visit within 14 days. The bill directly affects healthcare providers offering telemedicine abortion services, imposing fines up to $1,000 or up to 2 years in prison for violations. Exceptions apply for life-threatening medical emergencies, and the law explicitly excludes treatment for verified ectopic pregnancies. This bill targets the remote provision of abortion drugs, making in-person provider presence mandatory for such procedures.